{"id":1019062,"date":"2026-11-09T18:07:51","date_gmt":"2026-11-09T23:07:51","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/"},"modified":"2026-11-09T18:07:51","modified_gmt":"2026-11-09T23:07:51","slug":"maplight-therapeutics-to-participate-in-upcoming-investor-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/","title":{"rendered":"MapLight Therapeutics to Participate in Upcoming Investor Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p>SAN FRANCISCO and BOSTON, Nov.  09, 2026  (GLOBE NEWSWIRE) &#8212; MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference:<\/p>\n<p>\n        <strong>Event<\/strong>: 2026 Jefferies Global Healthcare Conference (London, UK)<br \/><strong>Date<\/strong>: Wednesday, November 18<sup>th<\/sup><br \/><strong>Format<\/strong>: Presenting and hosting 1&#215;1 meetings<\/p>\n<p>Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the \u201cEvents &amp; Presentations\u201d page on the Investor section of the company\u2019s website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=PeJq45jhjv5_L4BBK9zPtBS-0WUVQLjQYjTHEo0Rw-fMzrML81meNxtbdp1A1k6F9Xv63uREX6AhPKcJ4snZw1V17jOZr_vdlnKLR0SWln-sCGv1ZmmPsXxCujDVVN4QBYwUZe5Vi2vxR_QtkcDRFUeY8Q7G2S6jTCotVcO2Og5aYs6uzWwZGzYOEPaq_Bux\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.maplightrx.com\/news-events\/events-presentations<\/a>.<\/p>\n<p>\n        <strong>About MapLight Therapeutics<\/strong>\n      <\/p>\n<p>MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the lack of circuit-specific pharmacotherapies available for patients. The Company\u2019s discovery platform holds the potential to fill this void by identifying neural circuits causally linked to disease and targeting those circuits for therapeutic modulation. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=XCLLpaSK9VpkUpbFm_flHLZ4rkgWyBoH3Mflls5xgeVGbu_sPTcU8ocX5FlJs95ylenrft2EJdKRsk31OGY7e1aKY4zxndgnGh3rQBVO_VI=\" rel=\"nofollow\" target=\"_blank\">www.maplightrx.com<\/a>.<\/p>\n<p>\n        <strong>For investor inquiries: <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=CRbYq3_MZ74eZMrBuNvS6pxLk23KmKT-edYMJpQvbURbTED0mR_MF-mklchM7-vSWxM6Vw6Pylb4dkYevYbgTxJ0Ys-WxnXS5sz0FPsgULmpWYTwNz8zCylie39i4uob\" rel=\"nofollow\" target=\"_blank\">investors@maplightrx.com<\/a>\n      <\/p>\n<p>\n        <strong>For media inquiries: <\/strong><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=3AcUmSIIqwPfutYR8c4Flwf7Nonlp0x5aZvyGANZra_oM5IRqH2F6QiVX99dMGZOs6RURlMsg1K0JVmJb0A3JnO4IDpjRTncB1gYCBpRGCg=\" rel=\"nofollow\" target=\"_blank\">media@maplightrx.com<\/a>\n      <\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODA3NDA0MTItZjYyNy00MDYzLTlhZjUtZGZjNDg0MTA3MTk1LTEyNzIzNzgtMjAyNi0xMS0wOS1lbg==\/tiny\/MapLight-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN FRANCISCO and BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference: Event: 2026 Jefferies Global Healthcare Conference (London, UK)Date: Wednesday, November 18thFormat: Presenting and hosting 1&#215;1 meetings Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the \u201cEvents &amp; Presentations\u201d page on the Investor section of the company\u2019s website at https:\/\/ir.maplightrx.com\/news-events\/events-presentations. About MapLight Therapeutics MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MapLight Therapeutics to Participate in Upcoming Investor Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1019062","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN FRANCISCO and BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference: Event: 2026 Jefferies Global Healthcare Conference (London, UK)Date: Wednesday, November 18thFormat: Presenting and hosting 1&#215;1 meetings Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the \u201cEvents &amp; Presentations\u201d page on the Investor section of the company\u2019s website at https:\/\/ir.maplightrx.com\/news-events\/events-presentations. About MapLight Therapeutics MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the &hellip; Continue reading &quot;MapLight Therapeutics to Participate in Upcoming Investor Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-09T23:07:51+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"MapLight Therapeutics to Participate in Upcoming Investor Conference\",\"datePublished\":\"2026-11-09T23:07:51+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/\"},\"wordCount\":187,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/\",\"name\":\"MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\",\"datePublished\":\"2026-11-09T23:07:51+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MapLight Therapeutics to Participate in Upcoming Investor Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/","og_locale":"en_US","og_type":"article","og_title":"MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk","og_description":"SAN FRANCISCO and BOSTON, Nov. 09, 2026 (GLOBE NEWSWIRE) &#8212; MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference: Event: 2026 Jefferies Global Healthcare Conference (London, UK)Date: Wednesday, November 18thFormat: Presenting and hosting 1&#215;1 meetings Where available, access to the live webcasts of these events, as well as archived recordings, will be posted under the \u201cEvents &amp; Presentations\u201d page on the Investor section of the company\u2019s website at https:\/\/ir.maplightrx.com\/news-events\/events-presentations. About MapLight Therapeutics MapLight Therapeutics is a clinical-stage biopharmaceutical company focused on improving the lives of patients suffering from debilitating central nervous system disorders. The Company was founded by globally recognized leaders in psychiatry and neuroscience research to address the &hellip; Continue reading \"MapLight Therapeutics to Participate in Upcoming Investor Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2026-11-09T23:07:51+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"MapLight Therapeutics to Participate in Upcoming Investor Conference","datePublished":"2026-11-09T23:07:51+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/"},"wordCount":187,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/","name":"MapLight Therapeutics to Participate in Upcoming Investor Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=","datePublished":"2026-11-09T23:07:51+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTg3MzYzOCM3OTU1MTUyIzIyNjA4Mjg="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/maplight-therapeutics-to-participate-in-upcoming-investor-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"MapLight Therapeutics to Participate in Upcoming Investor Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=1019062"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/1019062\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=1019062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=1019062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=1019062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}